NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ILMN

Illumina Inc

Jul 03 • 04:00PM ET

100.80

Dollar change +0.46
Percentage change 0.46	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: PACB VRTX TXG QGEN GH BIO MYGN IONS TWST OMIC

| Held by: IJH VTI VXF VB VO MDY VBR IBB VUG ARKK

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.10	Insider Own	2.89%	Shs Outstand	159.00M	Perf Week	7.05%
Market Cap	15.96B	Forward P/E	21.65	EPS next Y	4.66	Insider Trans	0.40%	Shs Float	153.72M	Perf Month	23.18%
Enterprise Value	17.33B	PEG	-	EPS next Q	1.02	Inst Own	99.82%	Short Float	4.10%	Perf Quarter	23.11%
Income	-965.00M	P/S	3.68	EPS this Y	1.59%	Inst Trans	1.24%	Short Ratio	2.70	Perf Half Y	-24.53%
Sales	4.34B	P/B	6.77	EPS next Y	10.18%	ROA	-11.90%	Short Interest	6.30M	Perf YTD	-24.57%
Book/sh	14.89	P/C	12.90	EPS next 5Y	8.47%	ROE	-23.82%	52W High	156.66 -35.66%	Perf Year	-4.45%
Cash/sh	7.81	P/FCF	18.22	EPS past 3/5Y	- -	ROIC	-21.94%	52W Low	68.70 46.72%	Perf 3Y	-44.66%
Dividend Est.	-	EV/EBITDA	10.00	Sales past 3/5Y	-1.15% 4.29%	Gross Margin	66.38%	Volatility	3.19% 3.21%	Perf 5Y	-71.19%
Dividend TTM	-	EV/Sales	4.00	EPS Y/Y TTM	25.55%	Oper. Margin	32.70%	ATR (14)	3.01	Perf 10Y	-52.64%
Dividend Ex-Date	-	Quick Ratio	1.48	Sales Y/Y TTM	-3.47%	Profit Margin	-22.25%	RSI (14)	80.46	Recom	2.32
Dividend Gr. 3/5Y	- -	Current Ratio	1.86	EPS Q/Q	203.98%	SMA20	10.77%	Beta	1.37	Target Price	103.90
Payout	-	Debt/Eq	1.10	Sales Q/Q	-3.25%	SMA50	19.62%	Rel Volume	0.61	Prev Close	100.34
Employees	10370	LT Debt/Eq	0.86	Earnings	May 08 AMC	SMA200	-9.89%	Avg Volume	2.34M	Price	100.80
IPO	Jul 28, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.24% 1.52%	Trades		Volume	1,423,748	Change	0.46%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-04-25	Reiterated	Citigroup	Neutral	$130 → $90
Feb-28-25	Downgrade	HSBC Securities	Buy → Hold	$100
Feb-10-25	Downgrade	Barclays	Equal Weight → Underweight	$130 → $100
Feb-07-25	Downgrade	TD Cowen	Buy → Hold	$177 → $140
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$190 → $165
Nov-12-24	Resumed	Morgan Stanley	Equal-Weight	$156
Oct-17-24	Upgrade	HSBC Securities	Hold → Buy	$180
Aug-28-24	Upgrade	Argus	Hold → Buy
Aug-16-24	Upgrade	Daiwa Securities	Neutral → Buy	$120 → $154
Aug-14-24	Upgrade	TD Cowen	Hold → Buy	$126 → $144
Aug-14-24	Upgrade	Barclays	Underweight → Equal Weight	$125
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$140
Jun-03-24	Resumed	Jefferies	Hold	$115
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185
Dec-15-23	Upgrade	Bernstein	Underperform → Mkt Perform
Dec-14-23	Initiated	Stephens	Overweight	$170
Dec-14-23	Initiated	Guggenheim	Buy	$155
Dec-13-23	Initiated	Wolfe Research	Outperform	$175

Show Previous Ratings

Jul-03-25 01:34AM	5 Must-Read Analyst Questions From Illumina's Q1 Earnings Call (StockStory)
Jun-30-25 04:01AM	Proteomic Biomarker Analytics Market Forecast Report 2025: Proteomics Steps Up Where Genomics Falls Short (GlobeNewswire)
Jun-26-25 08:07AM	Illumina Stock May Benefit From New Agreement to Acquire SomaLogic (Zacks)
Jun-25-25 08:00AM	Avance Biosciences Launches NGS Center of Excellence in Houston (PR Newswire)
12:16AM	Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy (PR Newswire)
05:52PM	Loading…
Jun-24-25 05:52PM	Illumina, Inc. (ILMN): A Bull Case Theory (Insider Monkey)
Jun-23-25 12:32PM	Illumina bets on proteomics with $425m SomaLogic purchase (Medical Device Network)
07:13AM	Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy (PR Newswire)
07:05AM	Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina (GlobeNewswire)
06:58AM	Illumina to buy SomaLogic for up to $425M (MedTech Dive)
01:35AM	Canaccord Raises Price Target Of Illumina, Inc. (ILMN). (Insider Monkey)
Jun-20-25 11:40AM	ADRNY vs. CLX: Which Stock Is the Better Value Option? (Zacks)
11:40AM	SGIOY or ZTS: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	HMY or FNV: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	GOOS vs. IDEXY: Which Stock Is the Better Value Option? (Zacks)
11:40AM	Loading…
11:40AM	FTRE vs. ILMN: Which Stock Should Value Investors Buy Now? (Zacks)
Jun-18-25 12:05AM	3 Reasons ILMN is Risky and 1 Stock to Buy Instead (StockStory)
Jun-15-25 04:00AM	QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) (Business Wire)
Jun-13-25 12:07PM	Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market Reach (Zacks)
Jun-10-25 04:01PM	lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics (PR Newswire)
08:26AM	ILMN Q1 Earnings Call: Clinical Growth and Cost Actions Offset Research and China Headwinds (StockStory)
May-30-25 09:27AM	Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? (Zacks)
May-29-25 11:52PM	Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis (Insider Monkey)
02:01PM	Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis (PR Newswire)
07:37AM	Illumina widens access to cancer tests with Medicare and new CDx (Medical Device Network)
May-28-25 02:32PM	Stifel Affirms Buy Rating on Illumina (ILMN) Stock (Insider Monkey)
09:15AM	Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies (PR Newswire)
08:12AM	Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain? (Zacks)
May-25-25 11:34PM	Life Sciences Tools & Services Stocks Q1 Recap: Benchmarking Illumina (NASDAQ:ILMN) (StockStory)
May-21-25 09:05AM	3 Top Genomics Stocks to Add to Your Portfolio in 2025 (Zacks) -5.75%
08:49AM	Loading…
May-20-25 08:49AM	Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software (Zacks)
May-14-25 04:05PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
07:43AM	Illumina, Inc. (ILMN): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying (Insider Monkey)
May-13-25 09:16AM	Investing in Illumina (ILMN)? Don't Miss Assessing Its International Revenue Trends (Zacks)
09:15AM	Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications (PR Newswire)
May-10-25 10:57AM	Illumina price target lowered to $135 from $160 at Stifel (TipRanks)
May-09-25 10:56AM	SEC ends probe of Illuminas Grail acquisition (MedTech Dive)
09:10AM	Q1 2025 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
08:49AM	Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock Dips (Zacks)
03:40AM	Illumina Inc (ILMN) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
May-08-25 07:30PM	Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:40PM	Analyst Report: Illumina, Inc. (Morningstar Research)
06:00PM	Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates (Zacks)
04:55PM	Illumina: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 (PR Newswire)
May-07-25 05:20PM	Illumina Q1 2025 Earnings Preview (Seeking Alpha)
08:26AM	Q1 2025 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents)
May-06-25 08:38AM	Here's Why Artisan Mid Cap Fund Decided to Exit Illumina (ILMN) (Insider Monkey)
May-05-25 10:00AM	Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
09:15AM	Unveiling Illumina (ILMN) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
May-01-25 11:05AM	How AI And Robotics Are Transforming Real Estate (Seeking Alpha)
10:01AM	Illumina (ILMN) Earnings Expected to Grow: Should You Buy? (Zacks)
09:15AM	Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development (PR Newswire)
Apr-30-25 07:33AM	Baron Focused Growth Fund Q1 2025 Shareholder Letter (Seeking Alpha)
Apr-24-25 07:57AM	Should You Hold Illumina (ILMN)? (Insider Monkey)
01:15AM	Artisan Mid Cap Fund Q1 2025 Commentary (Seeking Alpha)
Apr-22-25 12:00PM	Patient Capital Management Q1 2025 Investment Review (Seeking Alpha)
Apr-21-25 04:47PM	This Cancer Test Could Become Routineand a Big Seller, Says Analyst (Barrons.com)
02:59PM	Illumina, Inc. (ILMN): Among Recent Activist Investor Campaigns (Insider Monkey)
Apr-18-25 05:05AM	Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks (StockStory)
05:00AM	Illumina, Tempus AI partner to drive genomic testing beyond cancer (MedTech Dive)
Apr-16-25 08:45AM	Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations (GlobeNewswire)
Apr-15-25 12:54PM	Squawk Pod: VA Governor Youngkin on DOGE & $2.2B to Harvard on hold - 04/15/25 Audio Only (CNBC TV)
09:15AM	Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation (PR Newswire)
Apr-12-25 09:32AM	GRAIL's Galleri Progresses While Back In Accumulation Levels (Seeking Alpha)
Apr-10-25 04:05PM	Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025 (PR Newswire) -6.61%
01:30PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Apr-04-25 09:40AM	Here's Why Illumina (ILMN) is a Strong Value Stock (Zacks)
Apr-01-25 12:10PM	Argus cuts Illumina target, sees buying opportunity (TipRanks)
Mar-31-25 09:03AM	The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics (Zacks)
Mar-30-25 07:10AM	abrdn World Healthcare Fund Q4 2024 Commentary (Seeking Alpha)
03:50AM	abrdn Life Sciences Investors Q4 2024 Commentary (Seeking Alpha)
03:25AM	abrdn Healthcare Opportunities Fund Q4 2024 Commentary (Seeking Alpha)
Mar-28-25 09:39AM	Promising Genomics & Synthetic Biology Stocks to Consider in 2025 (Zacks)
Mar-27-25 10:13AM	How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain (Investor's Business Daily)
08:35AM	Is Illumina Undervalued After An 83% Drop In Its Stock Price? (SeekingAlpha)
Mar-25-25 02:04PM	Cintas, UPS, Illumina: Market Minute (Yahoo Finance Video)
09:52AM	Activist Investor Meister to Join Illuminas Board (The Wall Street Journal)
09:10AM	Illumina shares rise on WSJ report activist investor Meister will join board (Investing.com)
09:00AM	Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors (PR Newswire)
08:18AM	Activist investor Keith Meister to join Illumina's board (Reuters)
Mar-24-25 12:36PM	Is Illumina, Inc. (ILMN) the Best Diagnostics Stock to Invest in Right Now? (InsiderMonkey)
11:47AM	Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain? (Zacks)
Mar-20-25 07:00AM	Invesco Global Fund Q4 2024 Commentary (SeekingAlpha)
Mar-19-25 09:15AM	Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery (PR Newswire)
Mar-18-25 09:40AM	Why Illumina (ILMN) is a Top Value Stock for the Long-Term (Zacks)
05:13AM	Illumina, Inc. (ILMN): Among the Best Biotech Stocks to Buy According to Billionaires (Insider Monkey)
Mar-17-25 09:23AM	Jim Cramer on Illumina (ILMN): A Challenged Company That He Doesnt Prefer (Insider Monkey)
Mar-11-25 09:46AM	Stocks to Watch Tuesday: Tesla, Southwest, Oracle, Illumina (The Wall Street Journal)
Mar-10-25 05:07PM	Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban (The Wall Street Journal)
04:22PM	Illumina lowers outlook due to China sales ban, to cut $100 million in costs (Reuters)
04:10PM	Illumina addresses recent developments in China (PR Newswire)
Mar-09-25 08:59PM	Why Illumina, Inc. (ILMN) Is Plunging So Far In 2025 (Insider Monkey)
Mar-07-25 04:01AM	3 Reasons to Sell ILMN and 1 Stock to Buy Instead (StockStory)
Mar-06-25 09:15AM	Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year (PR Newswire)
06:03AM	Illuminas DNA sequencers hit with China import ban (MedTech Dive)
Mar-05-25 12:54PM	China bans Illumina sequencer imports as US trade war intensifies (Medical Device Network)
Mar-04-25 04:47PM	Illumina Recoups Losses After China Retaliates Against Trump's Tariffs (Investor's Business Daily)
03:57PM	China bans imports of Illumina's gene sequencers amid tariff war (Yahoo Finance Video)
02:17PM	Illumina, airline downgrades, Walgreens: Market Minute (Yahoo Finance Video)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dhingra Ankur	SVP, Chief Financial Officer	May 12 '25	Buy	81.21	6,100	495,381	24,906	May 14 04:20 PM
Thaysen Jacob	Chief Executive Officer	May 12 '25	Buy	80.88	6,500	525,732	77,540	May 14 04:18 PM
Thaysen Jacob	Chief Executive Officer	May 13 '25	Buy	80.84	5,850	472,942	83,390	May 14 04:18 PM
JAKOB WEDEL CHRISTENSEN	Officer	May 06 '25	Proposed Sale	77.21	549	42,388		May 06 04:02 PM
ARNOLD FRANCES	Director	Feb 27 '25	Proposed Sale	93.48	120	11,218		Feb 27 11:07 AM
JAKOB WEDEL	Officer	Feb 18 '25	Proposed Sale	100.00	460	46,000		Feb 18 04:22 PM
PATRICIA L LECKMAN	Officer	Feb 18 '25	Proposed Sale	100.00	1,756	175,600		Feb 18 04:08 PM
CHARLES E. DADSWELL TRUST U/A/	Officer	Oct 14 '24	Proposed Sale	145.54	4,948	720,132		Oct 15 08:03 AM
CHARLES E. DADSWELL TRUST U/A/	Officer	Aug 15 '24	Proposed Sale	122.28	3,956	483,740		Aug 15 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ILMN

Illumina Inc

Upgrade your FINVIZ experience